Intracellular ion channel CLIC1: involvement in microglia-mediated β-amyloid peptide(1-42) neurotoxicity

Stephen D Skaper1, Laura Facci, Pietro Giusti

  • 1Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Largo "E. Meneghetti", 2, 35131, Padova, Italy. stephen.skaper@unipd.it

Insights

Chloride Intracellular Channel 1 (CLIC1) blockers protect neurons from amyloid-beta induced microglial toxicity in Alzheimer disease models. This suggests CLIC1 is a key target for neuroprotection in Alzheimer disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Microglia exacerbate central nervous system disorders like Alzheimer disease.
  • Ion channels in microglia contribute to neuropathologies.
  • Chloride Intracellular Channel 1 (CLIC1) is implicated in microglial neurotoxicity.

Purpose of the Study:

  • Investigate the role of CLIC1 in full-length amyloid-beta (Aβ1-42) induced microglial activation and neurotoxicity.
  • Determine if CLIC1 blockade protects neurons from Aβ1-42-stimulated microglia.
  • Examine CLIC1's role in lipopolysaccharide-stimulated microglial neurotoxicity.

Main Methods:

  • Utilized a Transwell™ system to co-culture microglia and neurons.
  • Administered Aβ1-42 and lipopolysaccharide (LPS) plus interferon-γ to microglia.
  • Pharmacologically inhibited CLIC1 using IAA-94 and niflumic acid.

Main Results:

  • Aβ1-42 exposure to microglia caused progressive neuronal loss over 3 days.
  • CLIC1 blockers IAA-94 and niflumic acid prevented Aβ1-42-induced neuronal injury.
  • LPS/interferon-γ-induced neuronal injury was not sensitive to CLIC1 inhibition, indicating selectivity.

Conclusions:

  • CLIC1 mediates neurotoxicity induced by Aβ1-42-activated microglia.
  • Pharmacological inhibition of CLIC1 offers neuroprotection against Aβ1-42 toxicity.
  • CLIC1 activation appears selective to certain microglial stimuli, like Aβ1-42.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...